However, small‐panel ctDNA testing incorporating these genes, particularly PTEN, could be valuable for identifying specific patient subgroups, such as those with rapidly progressive, poor‐prognosis ESCC resembling small cell lung cancer, potentially leading to fundamental changes in treatment strategies. Here, PTEN is linked to esophageal squamous cell carcinoma.